Clinical trial
Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for…
NCT02490878 · Alliance for Clinical Trials in Oncology, Other · Terminated
Key facts
| NCT number | NCT02490878 |
|---|---|
| Title | Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases |
| Official title | Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH Genentech, Inc. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Radionecrosis, Brain Metastases |
| Intervention type | Drug, Other |
| Interventions | bevacizumab, corticosteroids, placebo |
| Enrollment | 19 |
| Start date | Apr 1, 2016 |
| Primary completion | Feb 1, 2019 |
| Completion | Dec 15, 2022 |
| First posted | Jul 7, 2015 |
| Last update posted | Mar 23, 2023 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: